AI Is Supercharging Drug Development. The Tech is Slashing Early Research Costs and Timelines by Up to 70%
Artificial intelligence is rapidly transforming the pharmaceutical industry, dramatically reducing the time and cost required to develop new medicines before they ever reach human testing, according to a new survey.
International Business Times ·